Ledoux Jonathan, Greenwood Iain, Villeneuve Louis R, Leblanc Normand
Department of Physiology, University of Montréal and Research Centre, Montréal Heart Institute, Montréal, Québec, Canada.
J Physiol. 2003 Nov 1;552(Pt 3):701-14. doi: 10.1113/jphysiol.2003.043836. Epub 2003 Aug 22.
The role of the Ca2+-dependent phosphatase calcineurin (CaN) in the modulation of Ca2+-dependent Cl- channels (ClCa) was studied in freshly isolated rabbit coronary arterial myocytes. Immunocytochemical experiments showed that calmodulin-dependent protein kinase II (CaMKII) and CaN were distributed evenly throughout the cytoplasm of coronary myocytes at rest and translocated to the plasmalemma when intracellular Ca2+ was increased. ClCa currents (ICl(Ca)) elicited by cell dialysis with fixed intracellular Ca2+ levels up to 500 nM were inhibited by 10 microM cyclosporin A (CsA), a specific inhibitor of CaN, in a voltage-dependent manner, whereas currents evoked by 1 microM Ca2+ were not affected. Inhibition of CaN with CsA also led to a significant reduction in Ca2+ sensitivity of the channel at +50 mV; half-maximal activation increased from 363 +/- 16 nM Ca2+ in control to 515 +/- 40 nM Ca2+ in the presence of CsA. Similar effects were observed on ICl(Ca) when a specific peptide fragment inhibitor of CaN (CaN-AF, 5 microM) was dialysed into the cell via the pipette (500 nM Ca2+). Application of KN-93 (10 microM), a specific inhibitor of CaMKII, enhanced ICl(Ca) in myocytes dialysed with 1 microM Ca2+ but produced no significant effect on this current when the cells were dialysed with 350 or 500 nM Ca2+. These results are consistent with the notion that in coronary arterial cells, the activity of ClCa is enhanced by dephosphorylation of the channel or a closely associated regulatory protein. Moreover the balance of CaN and CaMKII regulating ICl(Ca) is dependent on the level of Ca2+ used to activate ICl(Ca).
在新鲜分离的兔冠状动脉心肌细胞中,研究了钙依赖性磷酸酶钙调神经磷酸酶(CaN)在调节钙依赖性氯离子通道(ClCa)中的作用。免疫细胞化学实验表明,钙调蛋白依赖性蛋白激酶II(CaMKII)和CaN在静息状态下均匀分布于冠状动脉心肌细胞的整个细胞质中,当细胞内Ca2+增加时,它们会转位至质膜。用固定的细胞内Ca2+水平(高达500 nM)进行细胞透析所引发的ClCa电流(ICl(Ca)),会被CaN的特异性抑制剂10 microM环孢素A(CsA)以电压依赖性方式抑制,而由1 microM Ca2+引发的电流则不受影响。用CsA抑制CaN也会导致通道在+50 mV时对Ca2+的敏感性显著降低;半数最大激活浓度从对照中的363±16 nM Ca2+增加到存在CsA时的515±40 nM Ca2+。当通过移液管将CaN的特异性肽片段抑制剂(CaN-AF,5 microM)透析到细胞中(500 nM Ca2+)时,对ICl(Ca)也观察到了类似的效应。应用CaMKII的特异性抑制剂KN-93(10 microM)可增强用1 microM Ca2+透析的心肌细胞中的ICl(Ca),但当细胞用350或500 nM Ca2+透析时,对该电流没有显著影响。这些结果与以下观点一致,即在冠状动脉细胞中,ClCa的活性通过通道或紧密相关的调节蛋白的去磷酸化而增强。此外,调节ICl(Ca)的CaN和CaMKII的平衡取决于用于激活ICl(Ca)的Ca2+水平。